Douglas S. Hawkins, Joseph G. Rajendran, Ernest U. Conrad III, James D. Bruckner and Janet F. Eary Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography Cancer 94
Article first published online: 12 JUN 2002 | DOI: 10.1002/cncr.10599
Neoadjuvant chemotherapy for pediatric bone sarcomas results in significant changes in [F-18]-fluorodeoxy-D-glucose (FDG) metabolism quantified by positron emission tomography (PET). In our study, FDG PET correlates with histopathologic response to chemotherapy in surgically excised pediatric bone sarcomas.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field